Shree Ganesh [SGRL] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Shree Ganesh

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shree Ganesh wins in 9 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShree GaneshSun PharmaceuticalBetter
P/E Ratio (TTM)30.8436.74Shree Ganesh
Price-to-Book Ratio4.655.30Shree Ganesh
Debt-to-Equity Ratio26.443.26Sun Pharmaceutical
PEG Ratio-1.19-1.89Sun Pharmaceutical
EV/EBITDA17.5823.33Shree Ganesh
Profit Margin (TTM)20.16%19.29%Shree Ganesh
Operating Margin (TTM)19.77%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)19.77%24.34%Sun Pharmaceutical
Return on Equity15.89%15.08%Shree Ganesh
Return on Assets (TTM)12.02%11.87%Shree Ganesh
Free Cash Flow (TTM)$74.69M$119.44BSun Pharmaceutical
Dividend YieldN/A1.26%N/A
1-Year Return-38.00%-14.60%Sun Pharmaceutical
Price-to-Sales Ratio (TTM)6.227.11Shree Ganesh
Enterprise Value$6.85B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio6.326.65Shree Ganesh
Gross Profit Margin (TTM)64.62%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$84$224Sun Pharmaceutical
Earnings per Share (Diluted)$17.03$43.39Sun Pharmaceutical
Beta (Stock Volatility)0.200.31Shree Ganesh
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shree Ganesh vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Shree Ganesh
Sun Pharmaceutical
Shree Ganesh Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh-3.10%-2.27%-14.23%-10.95%-31.40%-22.63%
Sun Pharmaceutical-0.31%2.80%3.33%-2.89%-7.84%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh-38.00%112.42%294.53%1,442.27%1,442.27%1,442.27%
Sun Pharmaceutical-14.60%70.78%218.03%80.00%690.16%2,608.73%

News Based Sentiment: Shree Ganesh vs Sun Pharmaceutical

Shree Ganesh

News based Sentiment: NEGATIVE

September brought disappointing financial results for Shree Ganesh Remedies, with a significant decline in net profit. Coupled with leadership changes and a falling stock price, the month paints a concerning picture for investors, suggesting potential challenges ahead despite a discounted valuation compared to peers.

View Shree Ganesh News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Shree Ganesh vs Sun Pharmaceutical

MetricSGRLSUNPHARMA
Market Information
Market Cap i₹6.85B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i6,4952,839,112
90 Day Avg. Volume i4,9492,655,594
Last Close₹508.95₹1,631.20
52 Week Range₹494.95 - ₹950.00₹1,548.00 - ₹1,952.25
% from 52W High-46.43%-16.45%
All-Time High₹950.05 (Jul 22, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-46.43%-16.79%
Growth Metrics
Quarterly Revenue Growth-0.01%0.10%
Quarterly Earnings Growth-0.26%-0.20%
Financial Health
Profit Margin (TTM) i0.20%0.19%
Operating Margin (TTM) i0.20%0.24%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i26.443.26
Cash & Liquidity
Book Value per Share (MRQ)₹113.00₹300.99
Cash per Share (MRQ)₹22.01₹108.88
Operating Cash Flow (TTM) i₹337.14M₹110.84B
Levered Free Cash Flow (TTM) i₹230.68M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A1.26%
Last 12-Month Dividend i₹0.00₹21.00

Valuation & Enterprise Metrics Analysis: Shree Ganesh vs Sun Pharmaceutical

MetricSGRLSUNPHARMA
Price Ratios
P/E Ratio (TTM) i30.8436.74
Forward P/E iN/A48.79
PEG Ratio i-1.19-1.89
Price to Sales (TTM) i6.227.11
Price to Book (MRQ) i4.655.30
Market Capitalization
Market Capitalization i₹6.85B₹3.92T
Enterprise Value i₹6.85B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i6.326.65
Enterprise to EBITDA i17.5823.33
Risk & Other Metrics
Beta i0.200.31
Book Value per Share (MRQ) i₹113.00₹300.99

Financial Statements Comparison: Shree Ganesh vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SGRLSUNPHARMA
Revenue/Sales i₹246.68M₹137.86B
Cost of Goods Sold i₹87.28M₹28.15B
Gross Profit i₹159.40M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹48.77M₹33.72B
EBITDA i₹79.58M₹47.66B
Pre-Tax Income i₹45.98M₹31.73B
Income Tax i₹11.53M₹8.70B
Net Income (Profit) i₹34.45M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SGRLSUNPHARMA
Cash & Equivalents i₹99.43M₹102.69B
Total Current Assets i₹775.75M₹526.24B
Total Current Liabilities i₹161.82M₹181.94B
Long-Term Debt i₹296.08M₹3.58B
Total Shareholders Equity i₹1.45B₹724.86B
Retained Earnings i₹1.10B₹578.62B
Property, Plant & Equipment i₹31.57M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SGRLSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,4952,839,112
Average Daily Volume (90 Day) i4,9492,655,594
Shares Outstanding i12.84M2.40B
Float Shares i2.20M1.04B
% Held by Insiders i0.76%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Shree Ganesh vs Sun Pharmaceutical

MetricSGRLSUNPHARMA
Last 12-Month Dividend i₹0.00₹21.00
Last 12-Month Dividend Yield iN/A1.26%
3-Year Avg Annual Dividend i₹0.33₹14.67
3-Year Avg Dividend Yield i0.15%0.46%
3-Year Total Dividends i₹1.00₹44.00
Ex-Dividend DateSep 07, 2023Jul 07, 2025